Account
Medtronic Inc.'s (MDT) fiscal fourth-quarter sales grew roughly 4%, but expenses related to employee layoffs and manufacturing consolidation caused earnings to fall 2.2%, masking the medical-devices company's improved revenue and margins.Medtronic has reduced employee headcount and taken other cost-cutting measures as it's been forced to adapt to pricing pressures and lower health-care utilization in the U.S. and Europe, while at the same time looking to increase its presence in faster-growing emerging markets like China. The company took a $172 million restructuring charge related to the elimination of about 2,000 employees. Roughly 65% of the cuts have already occurred, and were split between the U.S. and international facilities."Nearly half of the planned position reductions are related to manufacturing consolidation efforts. We also continue to reduce headcount in slow growing businesses and geographies," Chief Executive Omar Ishrak said. "These are never easy decisions but are ne...
Edwards Lifesciences Corp. (EW) reported disappointing sales of its flagship heart valves in the first quarter, leading the medical device firm to lower its full-yea...
Edwards Lifesciences Corp. (EW) reported disappointing sales of its heart valves in the first quarter, leading the medical device firm to lower its full-year sales a...
ARCA biopharma Inc. (ABIO) and medical-device maker Medtronic Inc. (MDT) agreed to collaborate on ARCA's proposed clinical trial for Gencaro, the biopharmaceutical c...
The prognosis for health care stocks is rosy.After riding a wave of uncertainty, health care company vital signals are now turning favorable. President Barack Obama'...
Medtronic CEO Omar Ishrak and Dr. John Noseworthy, Mayo Clinic CEO, on what the health-care law means to the average consumer.
Nuveen Asset Management chief equity strategist and senior portfolio manager Bob Doll weighs in on whether investors should fear the effects of the drama unfolding in Cyprus.
The march to make open-heart surgery a thing of the past continues.Edwards Lifesciences Inc. (EW) said its Sapien nonsurgical heart valve for elderly patients showed...
Edwards Lifesciences (EW) said a new version of its nonsurgical heart valve met its primary study goal in a late-stage trial, and that it would seek U.S. regulatory ...
Medtronic Inc. (MDT) said its medical device for treating high blood pressure continued to benefit patients after two years, providing more data to support the adopt...
Edwards Lifesciences Corp. (EW) said that a new version of its nonsurgical heart valve met its primary study goal in a late-stage trial, and that it would seek U.S. ...
United Capital Financial Advisors CEO Joe Duran and Profit Investments’ Eugene Profit discuss market growth and their stock picks.
FBN’s Stuart Varney breaks down the stories moving the markets early in the trading day.
Medtronic (NYSE:MDT) disclosed a 2.2% dip in fiscal fourth-quarter profits on Tuesday, but the medical-device maker's adjusted profits and revenue exceeded Wall Stre...
Medtronic Inc.'s (MDT) fiscal fourth-quarter earnings fell 2.2% as restructuring charges masked the medical-devices company's improved revenue and margins.Medtronic'...
The Supreme Court said Monday that it will consider the scope of whistleblower protections written into a 2002 federal law that encourages employees at public compan...
Stock indexes rallying to new highs have put investors on alert for a correction. Now they have something else to worry about: Too many individual stocks touching hi...
Swiss drugmaker Roche Holding AG is exploring a sale of its blood glucose meters business, three people familiar with the matter told Reuters on Wednesday, as the in...
I've read a few times today where folks opined that Dow 15K is just a number. I suppose that's true, but in this case, "the number" marked a fairly nice breakout. In...
Medtronic Inc. (MDT) is laying off 230 employees in its struggling spine division as it attempts to shift resources to business units with higher growth rates.The cu...